INT169015
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
FOXP3 expression is detectable in 40% of peripheral T cells in JIA patients. | |||||||||||||||
| |||||||||||||||
|
FoxP3 expression can be found in activated non-regulatory T cells [32-35]. | |||||||||||||||
| |||||||||||||||
|
Yan et al. found no difference in Foxp3 expression in CD4+CD25high regulatory T cells of SLE patients [134]. | |||||||||||||||
| |||||||||||||||
|
Opposite findings of increased Foxp3 expression in active disease were reported in one study of pediatric SLE [133]. | |||||||||||||||
| |||||||||||||||
|
In another study of synovial CD4+CD25high regulatory T cells in persistent and extended oligoarticular JIA, Massa et al. demonstrated that certain epitopes of human HSP increase the frequency of CD4+CD25high regulatory T cells and induce Foxp3 expression [109]. | |||||||||||||||
| |||||||||||||||
|
FoxP3 is preferentially and stably expressed in peripheral nTreg, even after proliferation [23,27]. | |||||||||||||||
| |||||||||||||||
|
Furthermore, we selected this particular marker of immune suppression because IL-2 has been shown to regulate FoxP3 expression in human CD4+CD25+ Tregs [48] by inducing STAT-3 binding of the first intron of the FoxP3 gene [20] and because STAT-3 inhibitors have been shown to inhibit Tregs [26,36]. | |||||||||||||||
| |||||||||||||||
|
Rather in the presence of proinflammatory cytokines and low concentration of TGF-beta, RORgammat expression is further upregulated, whereas FoxP3 expression and function are inhibited. | |||||||||||||||
| |||||||||||||||
|
The novel population is usually referred to as T regulatory cells (Tregs) and it is characterized by the expression of FoxP3. | |||||||||||||||
| |||||||||||||||
|
Treg cells expressing FoxP3 and/or IL-10 have a role in the immune homeostasis of the gut [103]. | |||||||||||||||
| |||||||||||||||
|
Furthermore, ectopic FoxP3 expression can phenotypically convert effector T-cells to regulatory T-cells [43]. | |||||||||||||||
| |||||||||||||||
|
Recent publication describes the expression of FoxP3 in pancreatic ductal adenocarcinoma cells, providing evidence that this could be an important tumor escape mechanism [84].
10. | |||||||||||||||
| |||||||||||||||
|
In fact in the presence of TGF-beta, CD4+ T-cells express both RORgammat and FoxP3, but RORgammat function is antagonized by FoxP3. | |||||||||||||||
| |||||||||||||||
|
Moreover, it appears that expression of FoxP3 by iTregs or IL-17 by TH17 cells may not be stable and that there is a great degree of flexibility in their differentiation options [5]. | |||||||||||||||
| |||||||||||||||
|
Elias et al. have shown that all-trans retinoic acid (ATRA) and other agonists of the retinoic acid receptor alpha (RARalpha) inhibit the formation of TH17 cells and promote FoxP3 expression [95], while Benson et al. have reported that ATRA enhances Treg growth and differentiation [96]. | |||||||||||||||
| |||||||||||||||
|
The likelihood of 'normal' FOXP3+ gene and endotoxin-tolerance among IRIS non-developers Why? | |||||||||||||||
| |||||||||||||||
|
CTLA-4 is constitutively expressed on Tregs that express the transcriptional factor FoxP3. | |||||||||||||||
| |||||||||||||||
|
Furthermore, nonsuppressive activated T effectors, increased in IBD mucosa, can express FoxP3 [112, 113]. | |||||||||||||||
| |||||||||||||||
|
Tregs are characterized by the expression of FoxP3 (Forkhead box P3), a transcriptional repression factor of the forkhead-winged helix family of transcription factors [16]. | |||||||||||||||
| |||||||||||||||
|
Moreover it has been demonstrated that a substantial percentage of Tregs had transient or unstable expression of the transcription factor FoxP3. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.